Orasis Pharmaceuticals
PrivateLast Round
Series D
Oct 8, 2024
Total Funding Raised
$126M
Company Overview
Orasis Pharmaceuticals is a pharmaceutical company that develops and markets ophthalmic solutions, including its FDA-approved prescription eye drop Qlosi for the treatment of presbyopia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orasis Pharmaceuticals Comparables
Compare Orasis Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LENZ Therapeutics | 87% | |
| AbbVie | 83% | |
| Nevakar Inc. | 82% |
Orasis Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 8, 2024 | ||||
| Debt | Oct 8, 2024 | ||||
| Series C | Sep 10, 2020 | ||||
| Series B | Jun 5, 2018 |
Orasis Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeSci Venture Partners | Series C, Series B |
| Arboretum Ventures | Series D |
| Maverick Ventures | Series C, Series D |
| Maverick Ventures Israel | Series C |
| SBI JI | Series D, Series B, Series C |
| Catalio Capital Management | Debt, Series D |
| Maverick Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2024
$68M round led by Johnson & Johnson Innovation and Arboretum Ventures.
- Sep 10, 2020
$30M round led by Bluestem Capital, SBI JI, and Visionary Ventures.
Recent news
Latest coverage and updates
- launchesJul 21, 2026
Orasis Pharma launched First Fill Free program on Apr 1st '25.
Orasis Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orasis Pharmaceuticals's valuation, stock price, and market status.
Is Orasis Pharmaceuticals a public or private company?
Orasis Pharmaceuticals is a private company.
What is the current stock price of Orasis Pharmaceuticals?
Orasis Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Orasis Pharmaceuticals worth (valuation)?
Valuation information for Orasis Pharmaceuticals is not publicly available.
Can I buy Orasis Pharmaceuticals stock?
Orasis Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orasis Pharmaceuticals's last funding round?
Orasis Pharmaceuticals's most recent funding round was Debt on October 8, 2024.
Who are the main investors in Orasis Pharmaceuticals?
Key investors in Orasis Pharmaceuticals include Arboretum Ventures, SBI JI, Visionary Ventures, Johnson & Johnson Innovation - JJDC, Inc., Bluestem Capital.
Will Orasis Pharmaceuticals IPO soon?
No public IPO plans have been announced for Orasis Pharmaceuticals.
How can I track Orasis Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orasis Pharmaceuticals's secondary market activity and sign up for updates.